ArticleOncotarget2017

Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.

Irene Brana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.